Google Übersetzer
Mink Therapeutics, Inc.
About
Mink Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
May 4 2026
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
Apr 17 2026
MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer
Apr 3 2026
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
Apr 2 2026
MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy